510(k) device
Silverlon Island Wound Dressing
Argentum Medical, LLC · Dressing, Wound, Drug (FRO, Unclassified) · First FDA decision May 1, 2014, newest Jan 14, 2019Chronic wounds and ulcers
Last checked: Nov 19, 2026Source: FDA, CMS, ClinicalTrials.gov, PubMed
FDA decisions
4
510(k) pathway
Device trials
1
Naming "Silverlon Island"
MAUDE reports
0
Brand "Silverlon Island", since 2015
PubMed studies
0
Mentioning "Silverlon Island"
AI summary across all sources
Written by AI from the FDA, CMS, ClinicalTrials.gov, MAUDE and PubMed data on this page, plus web searches for payment facts.
Product review deck
A slide deck reviewing Silverlon Island Wound Dressing
About ten slides on the technology, clinical evidence, regulatory history and commercialization, built with AI from the data on this page and web research, with sources. Download it as PowerPoint to edit or as PDF to share.
- Executive summary and key facts
- Technology
- Clinical evidence and trials
- Regulatory history and safety
- Reimbursement, market and competition
- Risks, outlook and sources
AI-written from public data and may contain mistakes. Check each fact against its source before relying on it. Not investment, legal, reimbursement or medical advice.
FDA decisions
The newest 4 of 4 decisions filed under this name.
K180570 · Decided Jan 14, 2019 · 315 days after receipt
Device type: Dressing, Wound, Drug (FRO) · General & Plastic Surgery
K143001 · Decided Nov 7, 2014 · 21 days after receipt
Device type: Dressing, Wound, Drug (FRO) · General & Plastic Surgery
K141573 · Decided Aug 28, 2014 · 77 days after receipt
Device type: Dressing, Wound, Drug (FRO) · General & Plastic Surgery
1 more FDA decisions with a free account
Medicare coverage
National and local coverage documents whose titles match this device or its device type. Payment add-ons (NTAP, pass-through, TCET) and likely codes are covered in the summary above.
No Medicare coverage document has a title matching this device or device type. Many devices are paid under existing codes without one.
Clinical trials
Device studies on ClinicalTrials.gov that name "Silverlon Island", any status and sponsor, newest update first.
- Silver Impregnated Dressings to Reduce Wound Complications in Obese Patients at Cesarean SectionTerminated
University of MichiganAcademic, hospital or other
NCT01528696 · 37 participants · Start Feb 2012 · Primary completion Jan 2013
Device: Silverlon; Standard Dressing · For: Obesity; Complications; Caesarean Section, Wound
Sites: Ann Arbor, Michigan
Adverse event reports (MAUDE)
Reports received since 2015 naming the brand "Silverlon Island", and for the whole product code for context.
This brand
0 reports: 0 malfunction, 0 injury, 0 death
Whole product code FRO
2,371 reports: 1,097 malfunction, 1,190 injury, 48 death
Newest reports for this brand
No MAUDE reports name this brand.
Recalls
From FDA's recall database. FDA lists each recalled product separately, so one recall can appear several times. A recall is often a correction or a labeling change, not a removal from the market.
No recall in FDA's data is linked to these FDA numbers.
Published research
The most relevant PubMed records for "Silverlon Island"[tiab]. The summary above synthesizes these.
No PubMed record mentions this device by name.
Other devices of this type
Also filed under product code FRO.
- Prontosan Wound GelB.Braun Medical, Inc. · 510(k) 2017
- Vashe Wound Solution (4.0 Oz), (8.5 Oz & (16.0 Oz)Puricore, Inc. · 510(k) 2014
- Acryderm Silver Antimicrobial Foam Wound DressingAcrymed, Inc. · 510(k) 2009
- LUOFUCON® Extra Silver Gelling Fiber Dressing Plus (Prescription use),LUOFUCON® Silver Antimicrobial Gelling Fiber Dressing Plus (OTC use)Huizhou Foryou Medical Devices Co., Ltd. · 510(k) 2024
- Silverlon® Wound Contact, Burn Contact DressingArgentum Medical, LLC · 510(k) 2024
- Sorbact Wound Dressing-Ribbon GauzeAbigo Medical AB · 510(k) 2017
- Exsalt SD7 Wound Dressing with Adhesive BackingExciton Technologies, Inc. · 510(k) 2014
- Bioderm Sciences Wound CreamBioderm Sciences, Inc. · 510(k) 2005
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.